Cargando…

Induction of Neutralizing Responses against Autologous Virus in Maternal HIV Vaccine Trials

A maternal vaccine capable of boosting neutralizing antibody (NAb) responses directed against circulating viruses in HIV-infected pregnant women could effectively decrease mother-to-child transmission of HIV. However, it is not known if an HIV envelope (Env) vaccine administered to infected pregnant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hompe, Eliza D., Mangold, Jesse F., Kumar, Amit, Eudailey, Joshua A., McGuire, Erin, Haynes, Barton F., Moody, M. Anthony, Wright, Peter F., Fouda, Genevieve G., Giorgi, Elena E., Gao, Feng, Permar, Sallie R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273346/ https://www.ncbi.nlm.nih.gov/pubmed/32493720 http://dx.doi.org/10.1128/mSphere.00254-20

Ejemplares similares

Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma
por: Kumar, Amit, et al.
Publicado: (2018)

Systemic administration of an HIV 1 broadly neutralizing dimeric IgA yields mucosal secretory IgA and virus neutralization
por: Fouda, Genevieve G., et al.
Publicado: (2016)

Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants
por: Martinez, David R., et al.
Publicado: (2020)

Maternal Humoral Immune Responses Do Not Predict Postnatal HIV-1 Transmission Risk in Antiretroviral-Treated Mothers from the IMPAACT PROMISE Study
por: Hompe, Eliza D., et al.
Publicado: (2019)

The function and affinity maturation of HIV-1 gp120-specific monoclonal antibodies derived from colostral B cells
por: Jeffries, Thomas L, et al.
Publicado: (2015)

Isolation of HIV-1-Neutralizing Mucosal Monoclonal Antibodies from Human Colostrum
por: Friedman, James, et al.
Publicado: (2012)

Impact of Maternal Immunity on Congenital Cytomegalovirus Birth Prevalence and Infant Outcomes: A Systematic Review
por: Coppola, Tiziana, et al.
Publicado: (2019)

Determinants of Tenascin-C and HIV-1 envelope binding and neutralization
por: Mangan, Riley J., et al.
Publicado: (2019)

Mutations that confer resistance to broadly-neutralizing antibodies define HIV-1 variants of transmitting mothers from that of non-transmitting mothers
por: Kumar, Amit, et al.
Publicado: (2021)

HIV envelope antigen valency on peptide nanofibers modulates antibody magnitude and binding breadth
por: Fries, Chelsea N., et al.
Publicado: (2021)

The Presence and Anti-HIV-1 Function of Tenascin C in Breast Milk and Genital Fluids
por: Mansour, Robin G, et al.
Publicado: (2016)

Assessing the impact of autologous neutralizing antibodies on viral rebound in postnatally SHIV-infected ART-treated infant rhesus macaques
por: Mainou, Ellie, et al.
Publicado: (2023)

Postnatally-transmitted HIV-1 variants are efficient at dendritic cell trans-infection and sensitive to autologous and heterologous neutralization
por: Fouda, GG, et al.
Publicado: (2012)

Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 Antibodies
por: Kelsoe, Garnett, et al.
Publicado: (2013)

Strategies for induction of HIV‐1 envelope‐reactive broadly neutralizing antibodies
por: Williams, Wilton B., et al.
Publicado: (2021)

Noncanonical placental Fc receptors: What is their role in modulating transplacental transfer of maternal IgG?
por: Martinez, David R., et al.
Publicado: (2018)

Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
por: Haynes, Barton F., et al.
Publicado: (2023)

Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants
por: Fouda, Genevieve G, et al.
Publicado: (2013)

Systemic administration of a broadly-neutralizing IgG antibody to generate HIV-neutralization responses in breast milk
por: Fouda, GG, et al.
Publicado: (2012)

Self-assembling peptide nanofiber HIV vaccine elicits robust vaccine-induced antibody functions and modulates Fc glycosylation
por: Chen, Jui-Lin, et al.
Publicado: (2022)

Leveraging antigenic seniority for maternal vaccination to prevent mother-to-child transmission of HIV-1
por: Nelson, Ashley N., et al.
Publicado: (2022)

Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models
por: Pollara, Justin, et al.
Publicado: (2019)

Understanding Early-Life Adaptive Immunity to Guide Interventions for Pediatric Health
por: Semmes, Eleanor C., et al.
Publicado: (2021)

Rare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in Women Chronically Infected with HIV-1
por: Tay, Matthew Zirui, et al.
Publicado: (2019)

HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site
por: McCurley, Nathanael P., et al.
Publicado: (2017)

Cost‐effectiveness of broadly neutralizing antibody prophylaxis for HIV‐exposed infants in sub‐Saharan African settings
por: Dugdale, Caitlin M., et al.
Publicado: (2023)

Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection
por: Semmes, Eleanor C., et al.
Publicado: (2022)

Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents
por: Garrido, Carolina, et al.
Publicado: (2021)

Mercury Exposure and Poor Nutritional Status Reduce Response to Six Expanded Program on Immunization Vaccines in Children: An Observational Cohort Study of Communities Affected by Gold Mining in the Peruvian Amazon
por: Wyatt, Lauren, et al.
Publicado: (2019)

HIV-1 Envelope gp41 Broadly Neutralizing Antibodies: Hurdles for Vaccine Development
por: Verkoczy, Laurent, et al.
Publicado: (2014)

HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2018)

The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous Neutralization
por: Schorcht, Anna, et al.
Publicado: (2022)

Isolation of a clonal lineage of IgA broadly neutralizing antibodies from a chronically infected Tanzanian subject
por: Moody, M, et al.
Publicado: (2012)

Harnessing early life immunity to develop a pediatric HIV vaccine that can protect through adolescence
por: Goswami, Ria, et al.
Publicado: (2020)

Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8
por: Soto, Cinque, et al.
Publicado: (2016)

Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2019)

RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses
por: Bradley, Todd, et al.
Publicado: (2018)

Restricted isotype, distinct variable gene usage, and high rate of gp120-specificity of HIV-1 Envelope-specific B cells in colostrum compared to those in blood of HIV-1-infected, lactating African women
por: Sacha, C.R., et al.
Publicado: (2014)

Maternal HIV-1 Env Vaccination for Systemic and Breast Milk Immunity To Prevent Oral SHIV Acquisition in Infant Macaques
por: Eudailey, Joshua A., et al.
Publicado: (2018)

Different adjuvanted pediatric HIV envelope vaccines induced distinct plasma antibody responses despite similar B cell receptor repertoires in infant rhesus macaques
por: Berendam, Stella J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l6jfcf0ntgkg9fhg9834tc59pp